|
J. Leighton Read, M.D. joined Alloy Ventures as a General Partner in October 2001 after 14 years as a biotechnology entrepreneur and investor. Dr. Read founded Aviron, a biopharmaceutical company focused on vaccines for infectious disease, where he served as Chairman and CEO until 1999 and Director until its acquisition by MedImmune (NASDAQ: MEDI) in 2002. He co-founded Affymax NV under the direction of Dr. Alejandro Zaffaroni and was a partner in Interhealth Limited, an investment partnership. Dr. Read is a director of Avidia Research Institute and Protein Mechanics, serves on the executive committee of the Biotechnology Industry Association and has won several awards as co-inventor of technology underlying the Affymetrix GeneChip. He received a BS in Psychology and Biology from Rice University in 1973, an MD from the University of Texas Health Science Center at San Antonio in 1976 and completed internal medicine training at the Peter Bent Brigham Hospital in Boston where he held appointments at the Harvard Medical School and School of Public Health. | 